Eye drops for dry eye: A 12-week study
Part of Eyes & vision clinical trials.
This trial tests whether an anti-inflammatory eye drop (ciclosporin A) can help dry eyes by changing immune cells on the eye's surface. It lasts 12 weeks and may be an option for people with moderate to severe dry eye.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You must have dry eye symptoms like a score of 23 or higher on the OSDI questionnaire, or have staining on your eye surface, or low tear film height
- You cannot have used steroid, ciclosporin, lifitegrast, or anti-inflammatory eye drops in the last 6 months
- You cannot wear contact lenses or have had eye surgery in the last 4–6 weeks (or 6 months for surgery)
- You cannot be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a newer cyclosporine drop (Vevye) works better than a generic cyclosporine drop for people with dry eye disease. You will use one of the two drops for 8 weeks and have eye exams to see how your symptoms and eye health change.
This study tests whether over-the-counter lubricating eye drops can improve dry eye symptoms and eye comfort. It compares the drops to no treatment to see how well they work.
This study tests an eye drop called lifitegrast for people with dry eye disease. It looks at whether the drops can improve eye comfort, reduce dryness, and help eye surface health. You may be able to join if you have had dry eye symptoms and used artificial tears in the past month.
This study tests two types of preservative-free eye drops to see which is more effective for people with mild to moderate dry eye disease. You will use one of the drops as directed, and the study will monitor your symptoms and eye health over time.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
This trial tests different doses of a new eye drop (HUC1-394) to see which dose works best for people with moderate to severe dry eye disease. You may qualify if your dry eye symptoms have lasted at least 3 months and you have low tear production along with other signs of dry eye.
Hear when a new Dry Eye Disease (DED) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.